Adam invests at the intersection of biology, healthcare, technology and data. He is interested in the digitization of healthcare; genomics and coding biology; the microbiome; bionics and cyborgs; neuroscience and brain-computer interfaces; next-gen bio-imaging; regenerative medicine; synthetic biology; human performance; and other areas of applied hard sciences
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Dimension | Founder & Managing Partner | Mar 1, 2022 | — | Detail |
Pager | Board Member | Apr 1, 2014 | — | Detail |
Science 37 | Board Member | — | — | Detail |